NCT03098940

A Bioavailability Study on Dronabinol

A Two Part, Open Label, Randomized, Four Period Cross-over Study to Compare the Bioavailability of Two Different Dronabinol Formulations in Healthy Male and Female Volunteers

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Axim Biotechnologies · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This study is a two part study

Detailed description

This study is a two part, open label, randomized, four periods cross-over study with a washout of at least 1 week between subsequent dosing occasions

Conditions

• THC

Interventions

Type	Name	Description
DRUG	Chewing Gum	During the study healthy subjects will receive single doses of the various strengths of dronabinol

Timeline

• Start date: 2018-01-01
• Primary completion: 2018-04-01
• Completion: 2018-09-01
• First posted: 2017-04-04
• Last updated: 2017-04-04

Regulatory

• FDA-regulated drug study